Abstract
Purpose
To report the 2-year outcomes of whole breast intensity-modulated radiotherapy (IMRT) after conserving surgery for early breast cancer (EBC) delivered with static angle tomotherapy (TomoDirect) (TD).
Methods
A prospective cohort of 120 EBC patients underwent whole breast IMRT with TD between 2010 and 2012. Radiation was delivered to a conventionally fractionated whole breast total dose of 50 Gy with TD, followed by a sequential conventionally fractionated tumor bed boost dose of 10–16 Gy with helical tomotherapy (HT). Clinical endpoints include acute and late toxicity, cosmesis, quality of life and local control.
Results
Median follow-up was 24 months (range 12–36 months); maximum detected acute skin toxicity was G0 22 %; G1 63 %; G2 12 % and G3 3 %. Predictors of acute dermatitis were as follows: volume of the whole breast minus boost volume receiving 105, 110 and 115 % of prescription dose, whole breast and boost volume, breast thickness and soft tissue thickness. Late skin toxicity was mild with no >G2 events. Cosmesis was good/excellent in 91.7 % of patients and fair/poor in 8.3 %. Quality of life was preserved over time, but for fatigue, transiently increased.
Conclusion
Adjuvant whole breast IMRT delivered sequentially with both TD and HT provides consistent clinical results. An observed unintended excessive dose outside the tumor bed might increase acute toxicity and eventually affect long-term clinical endpoints. The incorporation of the boost dose within the whole breast phase employing a simultaneous integrated boost (SIB) approach might mitigate this issue.
Similar content being viewed by others
References
Bantema-Joppe EJ, Schilstra C, de Bock GH, Dolsma WV, Busz DM, Langendijk JA, Maduro JH (2012) Simultaneous integrated boost irradiation after breast conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months’ follow up. Int J Radiat Oncol Biol Phys 83(4):e471–e477
Barnett GC, Wilkinson JS, Moody A, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE (2012) Randomized controlled trial of forward-planned intensity modulated-radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 82(2):715–723
Borca VC, Franco P, Catuzzo P, Migliaccio F, Zenone F, Aimonetto S, Peruzzo A, Pasquino M, Russo G, La Porta MR, Cante D, Sciacero P, Girelli G, Ricardi U, Tofani S (2012) Does TomoDirect 3DCRT represent a suitable option for post-operative whole breast irradiation? A hypothesis-generating pilot study. Radiat Oncol 7:211
Cante D, Rosa La Porta M, Casanova-Borca V, Sciacero P, Girelli G, Pasquino M, Franco P, Ozzello F (2011) Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early breast cancer: a prospective evaluation on 463 patients. Breast J 17(6):586–593
Cante D, Franco P, Sciacero P, Girelli G, Marra AM, Pasquino M, Russo G, Borva VC, Mondini G, Paino O, Barmasse R, Tofani S, Numico G, La Porta MR, Ricardi U (2013) Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the tumor bed after conserving surgery for early breast cancer. Med Oncol 30(2):518
Catuzzo P, Zenone F, Aimonetto S, Peruzzo A, Casanova Borca V, Pasquino M, Franco P, La Porta MR, Ricardi U, Tofani S (2012) Technical note: patient-specific quality assurance methods for TomoDirect(TM) whole breast treatment delivery. Med Phys 39(7):4073–4078
Caudell JJ, De Los Santos JF, Keene KS, Fiveash JB, Wang W, Carlisle JD, Popple R (2007) A dosimetric comparison of electronic compensation, conventional intensity modulated radiotherapy and tomotherapy in patients with early-stage carcinoma of the left breast. Int J Radiat Oncol Biol Phys 68(5):1505–1511
Ceilley E, Jagsi R, Goldeberg S, Grignon L, Kachnic L, Powell S, Taghian A (2005) Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61(2):365–373
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346
Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, Symonds-Tayler R, Tait D, Yarnold J, Breast Technology Group (2007) Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82(3):254–264
Fayers PM, Aarson NK, Bjordal K, Curran D, Groenvold M, On behalf of the EORTC quality of life study group (1999) EORTC QLQ-C30 scoring manual, 2nd edn. EORTC, Brussels
Fiandra C, Filippi AR, Catuzzo P, Botticella A, Ciammella P, Franco P, Borca VC, Ragona R, Tofani S, Ricardi U (2012) Different IMRT solutions vs 3D-conformal radiotherapy in early stage Hodgkin’s Lymphoma: dosimetric comparison and clinical considerations. Radiat Oncol 7:186
Franco P, Ricardi U (2012) TomoDirect to deliver static angle tomotherapy treatments. J Nucl Med Radiat Ther 3:5
Franco P, Catuzzo P, Cante D, La Porta MR, Sciacero P, Girelli G, Casanova Borca V, Pasquino M, Numico G, Tofani S, Meloni T, Ricardi U, Ozzello F (2011) TomoDirect: an efficient means to deliver radiation at static angles with tomotherapy. Tumori 97(4):498–502
Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR (2009) Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 74(3):689–694
Gonzalez VJ, Bucholz DJ, Langen KM, Olivera GH, Chauhan B, Meeks SL, Ruchala KJ, Haimerl J, Lu W, Kupelian PA (2006) Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 65(1):284–290
Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, Lala M, Martinez A, Schell S, Vicini FA (2007) Intensity modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68(5):1375–1380
Hong L, Hunt M, Chui C, Spirou S, Forster K, Lee H, Yahalom J, Kutcher GJ, McCormick B (1999) Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 44(5):1155–1164
Hurkmans CW, Cho BC, Damen E, Zijp L, Mijnheer BJ (2002) Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 62(2):163–171
Keller LM, Sopka DM, Li T, Klayton T, Li J, Anderson PR, Bleicher RJ, Sigurdson ER, Freedman GM (2012) Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center Experience. Int J Radiat Oncol Biol Phys 84(4):881–887
Murai T, Shibamoto Y, Manabe Y, Murata R, Sugie C, Hayashi A, Ito H, Miyoshi Y (2013) Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the Tomohelical mode. Radiat Oncol 8:68
National Cancer Institute Cancer Therapy Evaluation Program (2013) Common Toxicity Criteria for Adverse Events. 2013 Version 4.02. Available at http://ctep.cancer.gov. Accessed July 2013
Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144
Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckhman W, Vu TT, Truong P, Ackerman I, Paszat L (2008) A multicenter randomized trial of breast intensity modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26(13):2085–2092
Portmans P (2007) Evidence-based radiation oncology. Breast cancer. Radiother Oncol 84(1):84–101
Reynders T, Tournel K, De Coninck P, Heymann S, Vinh-Hung V, Van Parijs H, Duchateau M, Linthout N, Gevaert T, Verellen D, Storme G (2009) Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments. Radiother Oncol 93(1):71–79
Rose MA, Olivotto IA, Cady B, Koufman C, Osteen R, Silver B, Recht A, Harris JR (1989) Conservative surgery and radiation therapy for early stage breast cancer: long-term cosmetic results. Arch Surg 124(2):153–157
Schubert LK, Gondi V, Sengbush E, Westerly DC, Soisson ET, Paliwal BR, Mackie TR, Mehta MP, Patel RR, Tomé WA, Cannon GM (2011) Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy and topotherapy. Radiother Oncol 100(2):241–246
van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Hollander M, Langendijk JA (2007) Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 68(4):1018–1023
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Franco, P., Zeverino, M., Migliaccio, F. et al. Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series. J Cancer Res Clin Oncol 139, 1927–1936 (2013). https://doi.org/10.1007/s00432-013-1515-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1515-0